Cite
HARVARD Citation
Nelson, D. et al. (2014). Genome-Wide Association Study to Characterize Serum Bilirubin Elevations in Patients with HCV Treated with Gs-9256, An HCV Ns3 Serine Protease Inhibitor. Antiviral therapy. 19 (7), pp. 679-686. [Online].